Zydus Cadila gets DCGI nod to conduct Phase III trials for two-dose COVID vaccine

0
10

India’s drug regulator has given permission to Zydus Cadila for conducting Phase III trial on the two-dose regimen of its needle-free Covid-19 vaccine, ZyCoV-D. In a meeting held last month, the Subject Expert Committee (SEC), which advises the drug regulator-granted permission to the company for conducting Phase III trials on its Covid-19 vaccine.

Credits – Source – https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/zydus-cadila-gets-dcgi-nod-to-conduct-phase-iii-trials-for-two-dose-covid-vaccine/videoshow/86779315.cms

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.